A medtech company is investable when it can prove three things: the device works, it can reach the market, and someone will actually pay for it. In practice, that means clinical results, a regulatory path that investors understand, and a reimbursement or market-access plan that makes the product commercially viable.
Deloitte says the medtech investment landscape is shifting toward later-stage companies with demonstrated clinical results and market readiness, which makes early prototypes harder to fund. The FDA also matters here because many medtech products need clinical study data to support approval, and an investigational device exemption is used to collect safety and effectiveness data in that process. That combination is what investors are buying: evidence, not just engineering.
If the company cannot explain who the customer is, what problem the device solves, how long approval will take, and how revenue will arrive, it is usually too early for serious capital. A strong medtech pitch is less about hype and more about showing that science, regulation, and economics line up.
More in Small Business
Can AI replace human sales reps?
AI handles lead scoring, outreach drafting, forecasting, and routine follow-up at scale. But complex deals still hinge on trust, emotional nuance, judgment, and relationship-building — things AI simulates but does not possess. The real shift is hybrid sales teams, not full replacement.
📋 Small Business 4 weeks ago 2 min readDo I Need a Website If I Have a Facebook Page?
Yes. A Facebook page is rented space — you do not control the algorithm, own your audience, or rank in Google search the same way. A simple one-page site with your hours and phone gives you credibility and control.
📋 Small Business 14 weeks ago 3 min readDo I need to collect sales tax?
If you sell taxable goods or services and have nexus in a state, you must register, collect, and remit. Most services are exempt; goods usually are not. Rules vary by state.
📋 Small Business 12 weeks ago 3 min read